ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

JMT206

A development code. Also written as “JMT206 injection”.

Its studies are led by CSPC Pharmaceutical Group.

Furthest: phase 1, since Feb 12, 20262 company-led studies, 2 open or runningNext primary completion: Feb 28, 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
CSPC Pharmaceutical Group22 open or runningphase 1since Feb 12, 2026Feb 12, 2026Feb 28, 2027phase 1 · NCT07840729

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 12, 2026First study: phase 1 study in Healthy ParticipantsFirst studyNCT07419698 · 44 planned · China
  2. Sep 20, 2026Phase 1 study in Valid MeSH ConditiongsNCT07840729 · 90 planned · China

Ahead

  1. Feb 28, 2027Primary completion: phase 1 study in Valid MeSH ConditiongsNCT07840729

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07840729Valid MeSH Conditiongs · China1RecruitingFeb 28, 202790
NCT07419698Healthy Participants · China1RecruitingSep 1, 202644

How it is read

Names in the registry

  • “JMT206 injection”, 1 entry
  • “JMT206”, 1 entry

Codes read as this program: JMT206.

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.